Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Portola Pharmaceuticals
Biotech
Chutes & Ladders—Boehringer’s Corsico jumps to head dev at GSK
Boehringer’s Corsico jumps to head dev at GSK; Kite’s Polverino takes CSO role at Zymeworks; and Kymera taps former Alnylam executive as CMO.
Conor Hale
Sep 21, 2018 10:00am
Chutes & Ladders—CAR-T player Cellectis poaches Novartis exec
Aug 10, 2018 9:00am
Chutes & Ladders—J&J shakeup leaves Duato with largest portfolio
Jun 29, 2018 8:30am
FDA rejects Portola’s lead candidate, pushing shares down
Aug 18, 2016 9:50am
Following a pivotal failure, Portola lays out its case for betrixaban
May 27, 2016 10:27am
